LCM
LVM Capital Management Portfolio holdings
AUM
$964M
This Quarter Return
+13.77%
1 Year Return
+18.8%
3 Year Return
+70.29%
5 Year Return
+119.03%
10 Year Return
+295.51%
AUM
$750M
AUM Growth
+$750M
(+13%)
Cap. Flow
+$2.23M
Cap. Flow
% of AUM
0.3%
Top 10 Holdings %
Top 10 Hldgs %
43.61%
Holding
139
New
7
Increased
39
Reduced
54
Closed
5
Top Buys
| 1 |
Medtronic
MDT
|
$9.73M |
| 2 |
Exxon Mobil
XOM
|
$1.25M |
| 3 |
Pfizer
PFE
|
$974K |
| 4 |
Stryker
SYK
|
$814K |
| 5 |
Applied Materials
AMAT
|
$664K |
Top Sells
| 1 |
AT&T
T
|
$5.78M |
| 2 |
ATVI
Activision Blizzard Inc.
ATVI
|
$2.27M |
| 3 |
AbbVie
ABBV
|
$2.08M |
| 4 |
Lockheed Martin
LMT
|
$1.91M |
| 5 |
SPDR Gold Trust
GLD
|
$1.1M |
Sector Composition
| 1 | Technology | 27.91% |
| 2 | Healthcare | 19.67% |
| 3 | Consumer Staples | 10.83% |
| 4 | Real Estate | 7.05% |
| 5 | Communication Services | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Bio-Techne
TECH
$8.5B
| $202K | 0.03% |
+390
| New | +$202K |
|
127
Norfolk Southern
NSC
$62.8B
| $200K | 0.03% |
+672
| New | +$200K |
|
128
Vanguard Mid-Cap ETF
VO
$87.5B
| $200K | 0.03% |
+785
| New | +$200K |
|
129
Western Union
WU
$2.8B
| $186K | 0.02% |
10,400
| – | – |
|
130
Lineage Cell Therapeutics
LCTX
$267M
| $24K | ﹤0.01% |
10,000
| – | – |
|
131
Artelo Biosciences
ARTL
$12.2M
| – | – |
-12,000
| Closed | -$9K |
|
132
Conagra Brands
CAG
$9.16B
| – | – |
-20,403
| Closed | -$691K |
|
133
Twilio
TWLO
$16.2B
| – | – |
-724
| Closed | -$231K |
|
|
CBAY
134
DELISTED
Cymabay Therapeutics
CBAY
| – | – |
-15,000
| Closed | -$55K |
|